1Freedland Eric S. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates, a review. Nutrition& Metabolism, 2004, 1: 12.
2Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307: 426-430.
3Cben MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/Pre-B cell colony-enhancing factorin patients wth type 2 diabetes. J Clin Endocrinol Metab, 2006, Jan, 91 (1): 295-299.
4Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator-activated receptory have depot-specific effects on human preadipocyte differentiation. J Clin Invest, 1997, 100 (12): 3149-3153.
5Yoshinori, Archana, Masafumi, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. The Journal of Clinical Endocrinology& Metabolism, 2005, 87 (6): 2784-2791.
6Choi KC, Ryu OH, Lee KW, et al. Effect of PPAR-a and -c agonist on the expression of visfatin, adiponectin, and TNF-a in visceral fat of OLETF rats. Biochemical and Biophysical Research Communications, 2005, 336: 747-753.
7Ando H, Yanagihara H, Hayashi Y, et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytoklnes in mouse visceral adipose tissue. Endocrinology, 2005, 146 (12): 5631-5636.
8Hammarstedt A, Pihlajamaki J, Sopasakis VR, et al. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. Journal of Clinical Endocrinology & Metabolism, 2006, 91 (3): 1181-1184.
9Kralisch S, Klein J, Lossner U, et al. Isoproterenol, TNFalpha , and insulin downregulate adipose triglyceride lipase in 3T3- L1 adipocytes. Mol Cell Endocrinol, 2005, 240: 43-49.
10Kralisch S, Klein .1, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes.J Endocrinol, 2005, 185:R1-R8.
